Patents by Inventor Bryce Malcolm Buddle

Bryce Malcolm Buddle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymer particles and uses thereof
    Patent number: 10501505
    Abstract: The present invention relates to polymer particles and uses thereof. In particular the present invention relates to functionalized polymer particles, processes of production and uses thereof in the diagnosis, treatment or prevention of tuberculosis.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: December 10, 2019
    Inventors: Bernd Helmut Adam Rehm, Bryce Malcolm Buddle, David Neil Wedlock
  • POLYMER PARTICLES AND USES THEREOF
    Publication number: 20180015156
    Abstract: The present invention relates to polymer particles and uses thereof. In particular the present invention relates to functionalised polymer particles, processes of production and uses thereof in eliciting a cell-mediated immune response and in the treatment or prevention of diseases or conditions including those caused by intracellular pathogens.
    Type: Application
    Filed: March 8, 2017
    Publication date: January 18, 2018
    Inventors: Bernd Helmut Adam REHM, Natalie Anne PARLANE, David Neil WEDLOCK, Bryce Malcolm BUDDLE
  • POLYMER PARTICLES AND USES THEREOF
    Publication number: 20170008938
    Abstract: The present invention relates to polymer particles and uses thereof. In particular the present invention relates to functionalised polymer particles, processes of production and uses thereof in the diagnosis, treatment or prevention of tuberculosis.
    Type: Application
    Filed: February 4, 2015
    Publication date: January 12, 2017
    Inventors: Bernd Helmut Adam REHM, Bryce Malcolm BUDDLE, David Neil WEDLOCK
  • POLYMER PARTICLES AND USES THEROF
    Publication number: 20160175419
    Abstract: The present invention relates to polymer particles and uses thereof. In particular the present invention relates to functionalised polymer particles, processes of production and uses thereof in eliciting a cell-mediated immune response and in the treatment or prevention of diseases or conditions including those caused by intracellular pathogens.
    Type: Application
    Filed: October 29, 2015
    Publication date: June 23, 2016
    Inventors: Bernd Helmut Adam Rehm, Natalie Anne Parlane, David Neil Wedlock, Bryce Malcolm Buddle
  • ANTIGENIC COMPOSITIONS
    Publication number: 20120321669
    Abstract: The invention relates to antigenic compositions and to methods for immunizing animals using same. The antigenic compositions comprise a lipid formulation most usually in solid form, and at least one antigenic component. A preferred antigenic component is a living organism. In a preferred embodiment the composition is formulated for oral administration.
    Type: Application
    Filed: August 30, 2012
    Publication date: December 20, 2012
    Inventors: Frank Ernest Aldwell, Bryce Malcolm Buddle, Ian George Tucker
  • POLYMER PARTICLES AND USES THEREOF
    Publication number: 20120201846
    Abstract: The present invention relates to polymer particles and uses thereof. In particular the present invention relates to functionalised polymer particles, processes of production and uses thereof in eliciting a cell-mediated immune response and in the treatment or prevention of diseases or conditions including those caused by intracellular pathogens.
    Type: Application
    Filed: July 29, 2010
    Publication date: August 9, 2012
    Inventors: Bernd Helmut Adam Rehm, Natalie Anne Parlane, David Neil Wedlock, Bryce Malcolm Buddle
  • ANTIGENIC COMPOSITIONS
    Publication number: 20110274712
    Abstract: The invention relates to antigenic compositions and to methods for immunising animals using same. The antigenic compositions comprises a lipid formulation most usually in solid form, and at least one antigenic component. A preferred antigenic component is a living organism. In a preferred embodiment the composition is formulated for oral administration.
    Type: Application
    Filed: July 15, 2010
    Publication date: November 10, 2011
    Inventors: Frank Ernest Aldwell, Bryce Malcolm Buddle, Ian George Tucker
  • ANALOGUES OF PHOSPHATIDYLINOSITOL MANNOSIDES
    Publication number: 20100297156
    Abstract: The invention relates to compounds which are immunomodulatory compounds and, in particular, can induce IL-12 secretion. The invention also relates to compositions containing the compounds, precursors, and prodrugs of these compounds, use of these compounds as adjuvants in combination with vaccines, and use of these compounds for treatment of diseases or conditions relating to infection, atopic disorders, or cancer.
    Type: Application
    Filed: December 20, 2007
    Publication date: November 25, 2010
    Applicant: INDUSTRIAL RESEARCH LIMITED
    Inventors: Gary David Ainge, Bryce Malcolm Buddle, Michel Denis, Robyn Louise Wright, Darren Gibson, Ahivali Ashwin Gulab, David Samual Larsen, Gavin Frank Painter, Natalie Anne Parlane
  • Immunogenic compositions
    Patent number: 7758869
    Abstract: The invention relates to immunogenic compositions and to methods for immunizing animals using the same. The immunogenic composition comprises a lipid formulation most usually in solid form, and at least one immunogenic component. A preferred immunogenic component is a living organism. In a preferred embodiment the composition is formulated for oral administration.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: July 20, 2010
    Assignee: Immune Solutions Limited
    Inventors: Frank Ernest Aldwell, Bryce Malcolm Buddle, Ian George Tucker
  • Antigenic compositions
    Publication number: 20040234533
    Abstract: The invention relates to antigenic compositions and to methods for immunising animals using same. The antigenic compositions comprises a lipid formulation most usually in solid form, and at least one antigenic component. A preferred antigenic component is a living organism. In a preferred embodiment the composition is formulated for oral administration.
    Type: Application
    Filed: June 30, 2004
    Publication date: November 25, 2004
    Inventors: Frank Ernest Aldwell, Bryce Malcolm Buddle, Ian George Tucker